Progenics Pharmaceuticals IncLatest Progenics Pharmaceuticals Inc News and UpdatesCompany & Industry OverviewsWhat Does Nektar Therapeutics’ Valuation Trend Indicate?Under its immunology program, Nektar Therapeutics (NKTR) is developing NKTR-358 in collaboration with Eli Lilly and Company (LLY).
Company & Industry OverviewsWhat Does Nektar Therapeutics’ Valuation Trend Indicate?Under its immunology program, Nektar Therapeutics (NKTR) is developing NKTR-358 in collaboration with Eli Lilly and Company (LLY).
